Qilu Pharmaceutical
Jinan, China
Qilu Pharmaceutical Co., Ltd. is a leading, vertically integrated pharmaceutical company based in China, specializing in the development, manufacturing, and marketing of finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs). With a global presence, they are dedicated to providing high-quality and trustworthy medicines across diverse therapeutic areas.
How We Help
Core Technology
Small molecule drugs, biosimilars, monoclonal antibodies, chemical drugs, and biological products, with strong capabilities in chemical synthesis, genetic engineering, and fermentation. Their R&D includes targeted therapies, immunotherapies, and antibody-drug conjugates (ADCs).
Key Differentiators
Robust R&D capabilities with over 5,200 scientists across 6 R&D centers globally; Extensive manufacturing infrastructure with 11 domestic sites and USFDA/EDQM approval for sterile APIs; Global presence exporting to over 110 countries; Diverse product portfolio with over 350 marketed products; Strong commitment to international GMP standards.
Clinical Focus
Oncology, cerebrovascular & cardiovascular diseases, anti-infectives, psychological & neurological systems, respiratory system, ophthalmological diseases, nervous system diseases, endocrinology and metabolic disease, immune system diseases, and hemic and lymph diseases.
Target Customers
Global pharmaceutical companies (for APIs), hospitals, pharmacies, distributors, and agricultural sector (for crop protection products).
Product Stage
Mature
Company Info
- Business Model
- B2B (Business-to-Business)
- Founded
- 1958
- Total Funding
- 120,000,000
- Website
- en.qilu-pharma.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Achieved USFDA and EDQM approval for sterile APIs, indicating adherence to high international quality and regulatory standards. Known for many 'First-to-Launch' products in China.
MedStartr Index Score
?What do you think of Qilu Pharmaceutical?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.